The Acquisition Of CellGate Has Enabled Progen To Leverage Skills And Capabilities In The United States As Well As Australia |
|
|
Progen Pharmaceuticals Limited (PGLA-NASDAQ, PGL-ASX) |
|
|
“Through the CellGate acquisition, Progen is well positioned in both Australia as well as the United States and that allows us to leverage skills and capabilities that before would have been a real challenge, because we would have been able to do things well in Australia but not well in the United States. We are improving both of those things significantly and that makes managing a portfolio of technologies easier and more efficient.” - T. Justus Homburg (PGLA) (Interview published June 27, 2008) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Become a member and access our interview with: T. Justus Homburg, CEO (PGLA)
|
|
